t
Allergy Therapeutics PLC published a Block Listing Interim Review on 8 March 2023. For the period from 1 August 2022 to 28 February 2023, no ordinary shares were issued or allotted under the company's 2013 Long Term Incentive Plan. As of 28 February 2023, the balance of unallotted ordinary shares under the scheme remains 7,118,772.
| Date | 8 Mar 2023 |
| Time | 17:28:26 |
| Category | Capital structure |
| ID | 3552S |
Allergy Therapeutics plc
Block Listing Interim Review
Date 8 March 2023
|
Name of applicant: |
ALLERGY THERAPEUTICS PLC |
|||
|
Name of scheme: |
Allergy Therapeutics plc 2013 Long Term Incentive Plan |
|||
|
Period of return: |
From: |
1 August 2022 |
To: |
28 February 2023 |
|
Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission: |
10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017 |
|||
|
Balance of unallotted securities under scheme(s) from previous return: |
7,118,772 ordinary shares |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period: |
Nil |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
7,118,772 ordinary shares |
|||
|
Name of contact: |
Karley Cheesman |
|
Telephone number of contact: |
+44 (0) 1903 844 700 |